They provide access to sensory neuron cell bodies that connect peripheral tissues with the spinal cord. This makes it possible to examine how tumors, metastatic growth, or anticancer treatments affect sensory neurons directly. Findings can help connect changes in peripheral neural signaling with the development of pain during cancer progression or treatment.
The experimental system is designed to reveal whether tumor-related conditions or therapeutic exposure alter sensory neurons. Researchers can then relate those neuronal effects to cancer-associated pain mechanisms. Examining these responses separately from broader tumor biology helps clarify how metastatic growth and treatment effects may influence communication between peripheral tissues and the spinal cord.
After isolation, DRGs can support culture, imaging, electrophysiology, or molecular analysis. These approaches provide complementary views of sensory neurons, including their observable properties, electrical behavior, and molecular features. Using more than one analysis can help investigators connect cellular changes with neural signaling and evaluate their relevance to cancer-associated pain.
The procedure begins by exposing the spinal column and removing the vertebral tissue needed to access the ganglia. The DRGs are then located beside the spinal cord and carefully separated. The isolated tissue can subsequently be prepared for culture, imaging, electrophysiology, or molecular analysis, depending on the research question.
Careful separation preserves the isolated ganglia as a usable experimental preparation for downstream analysis. Because the procedure requires locating the ganglia beside the spinal cord and removing them after vertebral exposure, precise handling is central to obtaining tissue suitable for culture, imaging, electrophysiology, or molecular measurements in cancer studies.
Investigators can use dissected DRGs to evaluate how tumors, metastatic growth, or anticancer treatments affect sensory neurons. The resulting observations support analysis of peripheral neural signaling, investigation of cancer-associated pain mechanisms, and assessment of potential therapeutic interventions. Thus, the preparation links neural responses with tumor biology in a focused experimental setting.